Tarbox Family Office’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-141
Closed -$2K 826
2022
Q1
$2K Hold
141
﹤0.01% 849
2021
Q4
$2K Hold
141
﹤0.01% 923
2021
Q3
$3K Hold
141
﹤0.01% 841
2021
Q2
$3K Hold
141
﹤0.01% 848
2021
Q1
$3K Hold
141
﹤0.01% 796
2020
Q4
$2K Sell
141
-35
-20% -$457 ﹤0.01% 890
2020
Q3
$2K Buy
176
+100
+132% +$985 ﹤0.01% 838
2020
Q2
$1K Sell
76
-258
-77% -$2.14K ﹤0.01% 1051
2020
Q1
$3K Buy
334
+76
+29% +$903 ﹤0.01% 557
2019
Q4
$3K Hold
258
﹤0.01% 700
2019
Q3
$2K Buy
+258
New +$2.25K ﹤0.01% 779

Other funds holding SEM

Tarbox Family Office's SEM Position: Q2 2022 in Review

Tarbox Family Office sold out of Select Medical (SEM) in Q2 2022, closing a stake of 141 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in SEM in Q3 2019 and held it in 11 quarters. The position peaked at $3K in Q3 2021. 217 funds tracked by Wall St. Rank hold SEM as of Q2 2022.

  • Tarbox Family Office reported no remaining Select Medical position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 141 Select Medical shares in Q2 2022, an estimated $2K.
  • Tarbox Family Office first reported a position in Select Medical in Q3 2019 and held it in 11 quarters.
  • Tarbox Family Office's Select Medical position peaked at $3K in Q3 2021.
  • 217 funds tracked by Wall St. Rank held Select Medical as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.